Rochester, NY 8/10/2009 1:27:16 PM
After Hours - Amgen Inc., AMGN - Amgen Raises Company’s Earnings Guidance
Amgen Inc.
Amgen Inc. recently announced that the company now expects 2009 earnings of $4.80 to $4.95 per share and continues to expect revenue of $14.4 billion to $14.8 billion. Previously, the company’s earning guidance was of $4.55 to $4.75 per share and the current consensus earnings estimate is $4.57 per share on revenue of $14.32 billion for the year ending December 31, 2009
http://StockEinstein.com offers free daily stock alerts on companies ready to run. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Amgen Inc. is a biotechnology company that discovers, develops, manufactures and markets human therapeutics-based on advances in cellular and molecular biology. The Company operates in human therapeutics. It markets human therapeutic products in the areas of supportive cancer care, nephrology and inflammation.
StockEinstein.com has a dedicated team uncovering stocks ready to break and run. We apply time tested criteria and when one of these stocks meets or exceeds our benchmarks, our subscribers are immediately notified directly to their in-box.
This is a free service available only to our subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
During 2009 our alerts have resulted in an average price gain of 80%+.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
